1
FISA DE VERIFICARE A INDEPLINIRII STANDARDELOR MINIME NATIONALE in conformitate cu grila de evaluare a comisiei CNATDCU
MONITORUL OFICIAL AL ROMÂNIEI, PARTEA I, Nr. 890 bis/27.XII.2012
Anexa nr. 20 - COMISIA MEDICINĂ
STANDARDE MINIMALE NECESARE ŞI OBLIGATORII PENTRU CONFERIREA TITLURILOR DIDACTICE DIN
ÎNVĂŢĂMÂNTUL SUPERIOR ŞI A GRADELOR PROFESIONALE DE CERCETARE – DEZVOLTARE
Nr
crt Activitatea Tipul activității
Categorii si
restrictii Subcategorii
Indiatori
Kpi
0 1 2 3 4 5
1 Didactică
şi profe-
sională
1.1. cărți și
capitol în cărți
de specialitate
(cu ISBN)
– autor /
coautor
Criterii obligatorii:
1 capitol in tratat internațional = 1 carte națională;
1 carte internațional = 3 cărți naționale
Conferențiar – 1 carte de specialitate sau cel puțin 3 capitole într-un tratat
Profesor – 2 cărți (din care una ca prim autor sau autor unic) sau 6 capitole în tratate, de la ultima promovare
Îndeplinire: National
Carti ca autor
1. Victoria Burtea – Manual de semiologie psihiatrică, Casa de Editură
Venus, Iaşi, 2003.
2. Victoria Burtea – Manual de psihiatrie clinică, Casa de Editură Venus,
Iaşi, 2003
3. Victoria Burtea – Schizofrenia: repere clinico-terapeutice, Editura
Universităţii „Transilvania”, Braşov, 2004
4. Victoria Burtea – Breviar de psihopatologie. Editura Universităţii
„Transilvania”, Braşov, 2014
2
5. Victoria Burtea, Petru Ifteni – Psihopatologie – Cazuri clinice, Editura
Universităţii „Transilvania”, Braşov,
Criteriu indeplinit
1.2. cărți și
capitole în cărți
de specialitate
(cu ISBN) -
coordonator
Îndeplinire: internaționale
naționale
2 Cercetare 2.1. articole in
extenso in
reviste cotate
ISI Thomson
Reuters
Criterii obligatorii:
articole in reviste cu factor de impact, in calitate de autor principal, de la ultima promovare
Profesor – minim 6 articole
Conferențiar – minim 3 articole
Îndeplinire:
1. Moga M , Burtea V, Ifteni P, Socioeconomic status and psychological factors
involved in suicide, Revista de Cercetare si Interventie Sociala, 2014, vol. 45, pp.
230- 239
2. Szalontai A, Burtea V, Ifteni P. Blood Alcohol Concentration in Suicide: A
10 years Study, Revista de Cercetare si Interventie Sociala, 2014, vol. 46, pp. 144-
151
3. Szalontai A, Burtea V, Ifteni P. Predictors of Institutionalization in Dementia,
Revista de Cercetare si Interventie Sociala, 2015, vol. 49, pp. 249-257
4. Moga MA, Irimie M, Oanta A, Pascu A, Burtea V. Type-specific prevalence of
human papillomavirus by cervical cytology among women in Brasov, Romania.
Asian Pacific Journal of Cancer Prevention. 2014. Vol./is 15/16 (6887-92).
5. Ifteni P., Burtea V., Szalontay A.S., Moga M.A. Ethics of Treatment in Early
Psychosis, Revista Romana de Bioetica, in press
3
6. Moga MA, Arvatescu CA, Pratilas GC, Bigiu NF, Dinas K , Burtea V. The Role
of GaslessLaparoscopy in Differential Diagnosis of Acute Abdomen. Hippokratia,
in press, 2015.
Criteriu indeplinit
2.2. articole in
extenso in
reviste si
volumele unor
manifestări
științifice
indexate ISI
sau in alte BDI
Criterii obligatorii:
Profesor – minim 25 articole, din care 5 de la ultima promovare
Conferențiar – minim 15 articole din care 3 de la ultima promovare
1 articol ISI cu I.F. < 1 = 3 articole in reviste indexate BDI dar nu si invers
1 articol ISI cu I.F. ≥ 1 = 5 articole in reviste indexate BDI dar nu si invers (I.F. = impact factor)
Îndeplinire: Articole ISI cu I.F ≥ 1
1. Hans Rittmannsberger, Norman Sartorius, Victoria Burtea, Nora Căpraru, Pavel
Cernak, Mojka Dernovcek, Ionescu Dobrin, Rosa Frater, Jozef Hasto, Mieta
Hategan, Manfred Haushofer, J. Kafka, Siegfried Kasper, Rodica Macrea, Ludvik
Nabelek, Peter Nawka, Vladimir Nowotny, Thomas Platz, Adela Pojar, Christoph
Silberbauer, Matyas Trixler, Johannes Wancata, Elmar Windhager, Hans-Georg
Zapatoczky, Robert Zochling - Changing aspects of psychiatric inpatient treatment.
A census investigation in five European countries,European Psychiatry, 19 (2004),
483-488
2. Steven G. Potkin, Georges M. Gharabawi, Andrew J. Greenspan, Rammy
Mahmoud, Colette Kosik-Gonzalez, Marcia F.T. Rupnow, Cynthia A. Bossie,
Michael Davidson, Victoria Burtea, Young Zhu, Jintendra K. Tivedi – A double
blind comparison of risperidone, quetiapine and placebo in patients with
schizophrenia experiencing an acute exacerbation requiring hospitalisation,
Schizophrenia Research 85 (2006), 254-265
3. Ifteni P, Correll CU, Nielsen J, Burtea V, Kane JM, Manu P. Rapid clozapine
titration in treatment-refractory bipolar disorder, J Affect Disord. 2014
4
Sep;166:168-72. doi:10.1016/j.jad.2014.04.020. Epub 2014 May 20.
4. Ifteni P, Correll CU, Burtea V, Kane JM, Manu P., Sudden unexpected
death in schizophrenia: autopsy findings in psychiatric inpatients, Schizophr Res.
2014 May;155(1-3):72-6. doi: 10.1016/j.schres.2014.03.011. Epub 2014 Apr 4.
5. Ifteni P, Nielsen J, Burtea V, Correll CU, Kane JM, Manu P, Effectiveness and
safety of rapid clozapine titration in schizophrenia, Acta Psychiatr Scand. 2014
Jul;130(1):25-9. doi:10.1111/acps.12241. Epub 2013 Dec 20.
6. Ifteni P, Moga MA, Burtea V, Correll CU. Schizophrenia relapse after stopping
olanzapine treatment during pregnancy: a case report. Therapeutics and clinical risk
management. 2014. 10:901-904
Articole in reviste indexate BDI
1. Burtea V., Ifteni P., Sumedrea A.G., Mosoiu C. The treatment option in the
current practice in acute exacerbation of schizophrenia in Brasov county. Romanian
Journal of psychopharmacology, 2011, vol11, Issue 2, pp: 99-108
http://www.psychopharma.eu/revi ste/Vol.%2011,%20Nr.%202.pdf
2. Ifteni P., Burtea V., Teodorescu A. Patterns of antipsychotic use model in
treatment of Bipolar I disorder – a 12 months observational study. Bulletin Of The
Transilvania University, vol 4(53), Series VI, NO.1/2011, pp:73-76
http://webbut.unitbv.ro/bu2011/Series%20VI/BULETIN%20VI%20PDF/13_IFTE
NI.pdf
3. Burtea V., Ifteni P., Constantin D. Consideration about treatment noncompliance
in schizophrenia and hospital addressability. Bulletin Of The Transilvania
University, vol 4(53), Series VI, NO.1/2011, pp:67-72
http://webbut.unitbv.ro/bu2011/series%20vi/buletin%20vi%20pdf/12_burtea_mare.
4. Burtea V., Ifteni P., Teodorescu A., Rogozea L. Clozapine in treatment of
schizophrenia. Bulletin Of The Transilvania University, vol 4(53), Series VI,
NO.2/2011,pp:111-116
http://webbut.unitbv.ro/BU2011/Series%20VI/BULETIN%20VI/16 BURTEA.pdf
5
5. Ifteni P., Burtea V., Ifteni G., Taran L., Rogozea L. Admission to the psychiatric
emergency services of patients with alcohol- related mental disorder. Bulletin Of
The Transilvania University, vol 4(53), Series VI, NO.2/2011, pp:117-122
http://webbut.unitbv.ro/BU2011/S eries%20VI/BULETIN%20VI/17 _IFTENI.pdf
6. Burtea V., Rogozea L., Ifteni P. Ethical Significance of Lack of Insight and
Informed Consent in Schizophrenia. Bulletin Of The Transilvania University, vol
5(54), Series VI, NO.1/2012, pp:43-48
http://webbut.unitbv.ro/BU2012/Series%20VI/BULETIN%20VI%20PDF/07_BUR
TEA_ROGOZEA.pdf
7. Burtea V., Ifteni P., Pascu A. The QTC Interval in Patients Treated with
Antipsychotics. Archives of the Balkan Medical Union, vol 48, nr. 4, dec 2013, pp
404-405 http://umbalk.org/reviews/2013/u mb%204'2013%20rezumate.pdf
8. Burtea V., Ifteni P., Vârgă O., Teodorescu A. Analiza Fluentei Verbale in
Episodul Acut de Schizofrenie, Jurnalul Medical Brasovean nr.1- 2013, pp 54-58
http://webbut.unitbv.ro/jmb/JMB%202013%20nr%201/02_05_original%20burtea.p
df
9. Ifteni P., Burtea V., Teodorescu A. Caracteristicile socio- demografice ale
pacientilor cu schizofrenie si sindrom metabolic, Jurnalul Medical Brasovean nr.2-
2013, pp 50-55
http://webbut.unitbv.ro/jmb/JMB%202013%20nr%202/02_08_orig
inal%20ifteni.pdf
10.Dima L.,Ifteni, Pascu A, Burtea V., Moga M. New Theory in Schizophrenia and
Implications in Antipsychotics Development. Archives of the Balkan Medical
Union, 2014, vol. 49, no. 2, pp.
http://umbalk.org/reviews/2014/2 014%20-%202.pdf
11. Burtea V.,Ifteni P., Pascu A. Gender Differences in Major Depression with
Metabolic Syndrome. Archives of the Balkan Medical Union, 2014, vol. 49, no. 1,
pp. 40‐42
http://umbalk.org/reviews/2014/2 014%20-%201.pdf
6
12. Moga M.A., Arvătescu C.,Burtea V., Spulber R.,Pascu A.,Țînț D. Review of
Statins Treatment in Polycystic Ovary Syndrome. Archives of the Balkan Medical
Union in press
13. Moga M.A., Arvătescu C., Anastasiu C.,Ungureanu D.,Mironescu A., Burtea
V. Fetal Hydrothorax – a Case Report. Archives of the Balkan Medical Union in
press
14. Moga M., Bigiu N., Pascu A., Badea M., Burtea V. Polychlorinated Biphenils
Impact on Pregnancy. Archives of the Balkan Medical Union, 2014, vol. 49, no. 1,
pp. 61-65
http://umbalk.org/reviews/2014/u mb%201'2014%20rezumate.pdf
Criteriu indeplinit 2.3 granturi
/proiecte
castigate prin
competitie
(director
/responsabil
proiect)
Criterii obligatorii: Profesor – minim 3 granturi/proiecte, din care 1 ca director de proiect
Conferentiar – minim 2 granturi/proiecte,din care 1 ca responsabil de proiect
Îndeplinire: Granturi / proiecte - membru
1. Bioanalytical Methods – Linking Environmental Protection and Public Health –
51388 – IC – 1- 2003-RO- ERASMUS-DISSUC-2, MEMBRU
2. Leonardo da Vinci – Community Vocational Training Action Programme – PMH
– PROMENTALHEALTH, Exchange of Competencies for Trainers on Mental
Health Promotion – RO/2006/971125/Ex, MEMBRU
3.Matra - Reinforcement of the Integrated System of Extramural Mental Health
Care Services in Three Counties in Romania Asociatia de Servicii Sociale SCUT-
coordonator local, Spitalul de Psihiatrie si Neurlogie Isi II membru - partener,
Universitatea Transilvania – partener, MEMBRU
Granturi / proiecte - Director / responsabil de proiect
1. Proiect naţional de cercetare stiintifica cu terti si Universitatea “Transilvania” nr
23/16.09.2008 cu titlul „Impactul simptomatologiei anxios-depresive asupra
densitatii minerale a osului la subiectii sub 45 de ani”, in valoare de 10150 RON,
DIRECTOR
2. Proiect internaţional de cercetare stiintifica intre BIOLINERX (Israel) si
7
Universitatea „Transilvania” Brasov cu nr 155/8.01.2009, in valoare de 10500 Euro,
Sursa de finantare: BIOLINERX (Israel ), DIRECTOR
3.Proiect internaţional de cercetare stiintifica intre Stanley Medical Research
Institute si Universitatea „Transilvania” Brasov cu nr 6937/28.05.2009, in valoare
de 10200 EuroSursa de finantare: Stanley Medical Research Institute (US),
DIRECTOR
4. Proiect naţional de cercetare stiintifica cu terti si Universitatea “Transilvania” nr
6658/22.05.2009 cu titlul „Modelul de tratament al schizofreniei in judeţul Braşov”,
in valoare de 10100 RON Sursa de finantare: Sanofi, DIRECTOR
Criteriu indeplinit
2.4 articole
publicate in
rezumat in
reviste si
volumele unor
manifestari
stiintifice cu
ISBN sau ISSN
Criterii obligatorii: Profesor – minim 8 articole din care 3 in ultimii 5 ani
Conferentiar – minim 3 articole din care 1 in ultimii 5 ani
Îndeplinire: 1. Burtea V, Mosoiu C., Auditory Scene Analysis and Perceptual Streaming in
Patient with Schizophrenia. The Journal of the European College of
Neuropsychopharmacology, 2005, vol 15 ( Supp. 3 ), pp S525. Abstracts of the 18
ECNP Congress Amsterdam, Netherland, october 22-26,2005
2. Burtea V, Sangeorzan L, Rogozea L, Mosoiu C, Nedelcu A, Popescu M, Iliescu
M, Munteanu RI, Fraustosolis J, Sireteanu T, Cârstea I, Bagnar G. An Empirical
Investigation of Perceived Violence in Communication in Six Different University
Settings in Romania, WSEAS nov 07-09, Bucureşti, România, 2008; pp: 512-517;
proceeding indexat ISI.
http://www.wseas.us/e- library/conferences/2008/buchare st2/macmese/macmese-
S10.pdf
3. Rogozea L, Cristea L, Baritz M,Burtea V. Telemedicine and ethical dilemmas.
Proceedings Of The 8th Wseas International Conference On Artificial Intelligence,
Knowledge Engineering And Data Bases.Book Series: Artificial Intelligence Series
WSEAS 2009, 41-45
http://www.wseas.us/e- library/conferences/2009/cambridge/AIKED/AIKED03.pdf
8
4.Rogozea L, Miclaus R, Repanovici A, Burtea V., et al. Health promotion –
strategies and topics Educating the students from nursing and optometry
department. 9th WSEAS International Conference on Education and Educational
Technology. SELECTED TOPICS IN EDUCATION AND EDUCATIONAL
TECHNOLOGY 2010, 263-267
http://www.wseas.us/books/2010/Japan/EDU.pdf
5. Mosoiu C, Sumedrea A.G, Burtea V, Ifteni P. Fuzzy systems approach to
symptoms in schizophrenia. Proc. of the 11th WSEAS Int. Conf. On Neural
Networks, NN 10. Proceedings of the 11th WSEAS Int. Conf. On Evolutionary
Computing, EC '10, Proc. Of the 11th WSEAS Int. Conf. On Fuzzy Systems,
FS'10 2010, 268-272
http://www.wseas.us/e- library/conferences/2010/Iasi/NN ECFS/NNECFS-00.pdf
6. Ifteni P., Burtea V., Chirita V., Mosoiu C. The Influence of Metabolic
Syndrome in Major Depressive Disorder Outcome. WSEAS Athena, Greece,
September 28-30 2009; pp: 438- 440
7.Mosoiu C., Burtea V., Sumedrea A.G., Ifteni P. Syndrome Specification by
Factor Analysis in Schizophrenia. WSEAS Athena, Greece, September 28-30 2009;
pp: 511-515
8. Ifteni P., Burtea V., Mosoiu C. Prevention of Relapses in the Bipolar I Disorder:
a Comparative Study between Quetiapine Monotherapy vs. Quetiapine- Valproate
Combined Therapy. WSEAS Athena, Greece, September 28-30 2009; pp: 435- 437
9. Burtea VD., Burtea V., Mosoiu C., Sumedrea AG., Dimensions of Anxiety
Symptoms in Romanian Young Adult Subjects from Brasov County. WSEAS
Athena, Greece, September 28-30 2009, pp 507-510
http://www.wseas.us/elibrary/con ferences/2009/vouliagmeni/ACC
MM/ACCMM2-17.pdf
9
10. Burtea V.,Mosoiu C.,Vârciu M.,Leaşu F. The Overlap of Depression and
Anxiety Symptoms in a Community Sample of Romanian Young Adults.
Proceedings of 11th WSEAS International conference on Mathematical and
computational methods in science and engineering, September 2009, pp 503-506
http://www.wseas.us/elibrary/con ferences/2009/vouliagmeni/ACC
MM/ACCMM2-16.pdf
11. Dima L., Podasca C., Rogozea L.,Balescu A.,Burtea V. Hospital web pages – a
Brasov case study. Proceedings of 12th WSEAS International conference on
Mathematical and computational methods in science and engineering, November
2010, pp 331-335
http://www.wseas.us/elibrary/conferences/2010/Faro/MACMESE/ MACMESE-
55.pdf
12. Ifteni P., Burtea V., Mosoiu C., Rogozea L. Ethic aspects medical information
through computers and internet.WSEAS,2011, pp:159- 162
http://www.wseas.us/e- library/conferences/2011/Iasi/ED UTE/EDUTE-28.pdf
Criteriu indeplinit
2.5. proiecte
educationale si
de formare
continua
Îndeplinire:
3 Recunoa-
şterea şi
impactul
activităţii
Premii Îndeplinire:
Citări in reviste
ISI şi BDI - 0,05
pct/citare
Îndeplinire:
3.3 Prezentări
invitate în
plenul unor
manifestări
ştiinţifice
naţionale şi
internaţionale
Îndeplinire:
10
3.4.profesor
invitat (exclusive
ERASMUS)
3.5. membru în
colectivele de
redacţie sau co-
mitete ştiinţi-
fice, organizator
de manifestări
ştiinţifice
Îndeplinire: 1. Comitet de redactie Romanian journal of Psychopharmacology 2003
2. Comitet de redactie Jurnalul Medical Brasovean
3. Comitet Stiintific National - Simpozionul National de Psihiatrie. Personalitate normala
si patologice. Tulburari anxioase si de dispozitie. 2001
4. Comitet Stiintific International Conferinta Internationala " Enviornmental
Pollution and It's Impact on Public Health" 2008
5. Comitetul Stiintific Conferinta Nationala de Psihiatrie 2009
6. Comitet Stiintific Onorific Prima Consfatuire Nationala de Istorie a Psihiatriei
Romanesti 2009
7. Comitet Stiintific National Conference of Biological Psyhchiatry and
Psychopharmacology 2010
8. Comitet Stiintific International - International Academic Autumn School " Impact of
enviormental pollution on public health " 2011
9.Comitet Stiintific Al IV-Lea Congres National de Psihiatrie 2011
3.6 recenzor
pentru reviste şi
manifestări
ştiinţifice naţio-
nale şi interna-
ţionale indexate
ISI/BDI
Îndeplinire:
3.7 membru
comisii de
doctorat
(exclusiv
preşedinte) şi
abilitare
1. Universitatea de Medicina si Farmacie Craiova, Ordinul Rectorului Universitatii
de Medicina si Farmacie Craiova nr. 8/B din 29.06.2010 - membru referent in
comisie de sustinere a tezei de doctorat elaborata de Dna Raducanu M. Emilia
pentru obtinerea titlului stiintific de Doctor in Medicina.
3.8 experienţa
de management
în cercetare
şi/sau
Îndeplinire: I. I. Investigator principal in trialuri internationale. 1.TRIAL 100 – Stamina. An international, multicentre, double- blind,
randomised, placebo- controlled study of the safety and efficacy of Seroquel
11
învăţământ (Quetiapine fumarate) as add-on therapy with lithium and divalproex in the
treatment of acute mania. Investigator meeting - Monte Carlo, 23-25.07.2001
2. TRIAL 105 – Stamp 2. An international, multicentre, double- blind,
randomised, placebo- controlled study of the safety and efficacy of seroquel
(quetiapine fumarate) and lithium as monotherapy in the treatment of acute
mania. Investigator meeting - Monte Carlo, 23-25.07.2001
3. TRIAL RIS-SCP 402. A Randomised, Double-blind Study to Evaluate the
Efficacy and Safety of Risperidone vs. Quetiapine vs. Placebo in Subjects with
an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder.
Investigator meeting – Salonic, Grecia, septembrie 2003
4. EUFEST. The European First Episode Schizophrenia Trial – comparison of
outcome in first episode schizophrenia with different low dose antipsychotic
drug regimens. Investigator meeting – Bucureşti, noiembrie 2003; Paris,
20.06.2004
5. TRIAL 10124. A double blind, randomised study of long-term bifeprunox
efficacy, safety and tolerability in patients with chronic schizophrenia
6. TRIAL N3D/FOR-OCA-05. Multicentre,double-blind, placebo controlled,
rising dose, parallel group study of the efficacy and tolerability of ocaperidone
in schizophrenic patients. Investigator meeting – Colmar, Franţa, februarie 2004
7. TRIAL N3D/FOR-OCA-08. Multicentre, double-blind, placebo controlled,
rising dose, parallel group study of the efficacy and tolerability of ocaperidone
in schizophrenic patients – extension of N3D/FOR-OCA-05. Investigator
meeting – Colmar, Franţa, februarie 2004
8. STAGE. A 24-week, International, Multi-centre, Open- label, Flexibile-dose,
Randomised, Parallel-Group, Phase IV Study to Compare the Effect on Glucose
Metabolism of Quetiapine, Olanzapine and Risperidone in the Treatment of
Patients with Schizophrenia. Investigator meeting – Dresda, februarie 2004
9. REASSURE I. A 6-week, International, Multicenter, Double-blind, Double-
dummy, Randomized Comparison of the Efficacy and Safety of Sustained-
Release Formulation Quetiapina Fumarate (SEROQUEL) and Placebo in the
Treatment of Acutely Ill Patients with Schizophrenia. Investigator meeting –
Frankfurt, Germania, mai 2004
12
10. TRIAL RO76477-SCH-1010. A Double Blind, Placebo- Controlled,
Randomised Study Evaluating the effect of ER OROS Paliperidone Compared
to Placebo on Sleep in Subjects with Schizophrenia
11. TRIAL D1447C00144. Multicenter, randomised, Parallel- group, Double-
Blind, Placebo- controlled Phase III Study of the Efficacy and Safety of
Quetiapine Fumarate and Lithium as Monotherapy for up to 104 weeks
Maintenance Treatment of Bipolar I Disorder in Adult Patients, 2004
12. TRIAL TRIAL 041023. A Multicenter, randomised, Double- Blind, fixed-
dose, 6 weeks trial of the efficacy and safety of asenapine compared with
placebo using a haloperidol positive control in subjects with an acute
exacerbation of schizophrenia, phase IIIa, 2005-2006
13. TRIAL 041513. A double-blind, flexible dose, positive-controlled,
multicenter, long term extension of a randomized trial for subjects who have
completed the 6 weeks short term trial 041023; phase IIIa, 2006
14. TRIAL BL – 1020 Phase IIa, 2007-2008. An open-label, multicenter, six-
weeks, sequential cohort study designed to determine the safety and tolerability
of two dose ranges of BL-1020 in hospitalized subjects with chronic
schizoprenia or schizoaffective disorder
15. TRIAL BL – 1020 Phase IIb, 2008-2009. A six week, randomized,double-
blind, placebo- controlled, parallel group, multi-center, phase IIb study to
determine the eficacy, safety and tolerability of low and high non-overlapping
dose ranges of BL-1020 compared to placebo and Risperidone in patients with
acute exacerbations of schizophrenia
16. TRIAL ALL-S-01 Phase III, 2009-2010. Allopurinol in schizophrenia: a
randomized trial administering Allopurinol vs placebo as add-on to
antipsychotics in patients with schizophrenia or schizoaffective disorder
17. TRIAL CL3- 20098-083 Early effect of agomelatine on general interest in
outpatients with Major Depressive Disorder.
18. TRIAL P05691 2011 A Phase 3b, Multicenter,Double-Blind, Fixed-Dose,
Parallel Group, Three week Placebo Controlled Trial Evaluating the Safety and
Efficacy of Asenapine in Subjects with Bipolar 1 Disorder, Experiencing an
Acute Manic or Mixed Episode.
13
19. TRIAL P05692 2012-2014 A Multicenter,Double-Blind, Fixed- Dose,
Long Term Extension Trial, of the Safety of Asenapine in Subjects with
Bipolar 1 Disorder who Completed Protocol P05691
20. TRIAL P05688 2012-2014 A Multicenter, Randomized, Double-Blind,
Fixed-Dose,6 Week Trial of the Efficacy and Safety of Asenapine Compared
with Placebo Using Olanzapine as an Active Control in Subjects with an Acute
Exacerbation of Schizophrenia.
II. Sef Catedra de Specialitati Medicale 2008-2012
III. Director de Departament DFPC din anul 2013
3.9. participare
efectivă
manifestări
ştiinţific
Îndeplinire: